Lead Pharma CEL Models IP B.V.

Netherlands

Back to Profile

1-1 of 1 for Lead Pharma CEL Models IP B.V. Sort by
Query
Patent
United States - USPTO
Aggregations Reset Report
IPC Class
A61K 31/167 - Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol 1
A61K 31/18 - Sulfonamides 1
A61K 31/44 - Non-condensed pyridinesHydrogenated derivatives thereof 1
A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca 1
C07C 311/16 - Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom 1
See more
Found results for  patents

1.

ROR gamma (RORγ) modulators

      
Application Number 15102098
Grant Number 09738600
Status In Force
Filing Date 2014-12-03
First Publication Date 2016-10-20
Grant Date 2017-08-22
Owner
  • LEAD PHARMA CEL MODELS IP B.V. (Netherlands)
  • LEAD PHARMA HOLDING B.V. (Netherlands)
Inventor
  • Cals, Joseph Maria Gerardus Barbara
  • Nabuurs, Sander Bernardus

Abstract

15-16 are independently H, C(1-6)alkyl, C(3-6)cycloalkyl, C(3-6)cycloalkylC(1-3)alkyl, C(6-10)aryl, C(6-10)arylC(1-3)alkyl, C(1-9)heteroaryl, C(1-9)heteroarylC(1-3)alkyl, C(2-5)heterocycloalkyl or C(2-5)heterocycloalkylC(1-3)alkyl, all groups optionally substituted with F, Cl, C(1-2)alkyl, C(1-2)alkoxy or cyano.

IPC Classes  ?

  • C07C 317/44 - SulfonesSulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
  • A61K 31/167 - Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
  • C07D 213/75 - Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
  • A61K 31/18 - Sulfonamides
  • A61K 31/44 - Non-condensed pyridinesHydrogenated derivatives thereof
  • C07C 311/16 - Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
  • C07C 311/20 - Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
  • C07C 317/46 - SulfonesSulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca